Asthma in elite athletes

被引:0
|
作者
Elers, Jimmi [1 ]
Pedersen, Lars [1 ]
Backer, Vibeke [1 ]
机构
[1] Bispebjerg Hosp, Dept Resp Med, DK-2400 Copenhagen NV, Denmark
关键词
asthma; elite athletes; treatment; TUE; VCD; EXERCISE-INDUCED BRONCHOCONSTRICTION; CROSS-COUNTRY SKIERS; VOCAL CORD DYSFUNCTION; LEUKOTRIENE-RECEPTOR ANTAGONIST; AIRWAY INFLAMMATION; BRONCHIAL HYPERRESPONSIVENESS; INHALED CORTICOSTEROIDS; INDUCED BRONCHOSPASM; PERSISTENT ASTHMA; HIGH PREVALENCE;
D O I
10.1586/ERS.11.28
中图分类号
R56 [呼吸系及胸部疾病];
学科分类号
摘要
Expert Rev. Respir. Med. 5(3), 343-351 (2011) Asthma is frequently found among elite athletes performing endurance sports such as swimming, rowing and cross-country skiing. Although these athletes often report symptoms while exercising, they seldom have symptoms at rest. Moreover, compared with nonathletic asthmatic individuals, elite athletes have been shown to have a different distribution of airway inflammation and unequal response to bronchial provocative test. Elite athletes display signs of exercise-induced symptoms, for example, nonasthmatic inspiratory wheeze, vocal cord dysfunction and cardiac arrhythmias, which could limit their physical capacity. Elite athletes should undergo comprehensive assessment to confirm an asthma diagnosis and determine its degree of severity. Treatment should be as for any other asthmatic individual, including the use of beta 2-agonist, inhaled steroid as well as leukotriene-antagonist. It should, however, be noted that daily use of beta-agonists could expose elite athletes to the risk of developing tolerance towards these drugs. Use of beta 2-agonist should be replaced with daily inhaled corticosteroid treatment, the most important treatment of exercise-induced asthma. All physicians treating asthma should be aware of the doping aspects. Systemic beta 2-agonist intake is strictly prohibited, whereas inhaled treatment is allowed in therapeutic doses when asthma is documented and dispensation has been granted when needed.
引用
收藏
页码:343 / 351
页数:9
相关论文
共 50 条
  • [41] Two distinct phenotypes of asthma in elite athletes identified by latent class analysis
    Couto, Mariana
    Stang, Julie
    Horta, Luis
    Stensrud, Trine
    Severo, Milton
    Mowinckel, Petter
    Silva, Diana
    Delgado, Luis
    Moreira, Andre
    Carlsen, Kai-Hakon
    [J]. JOURNAL OF ASTHMA, 2015, 52 (09) : 897 - 904
  • [42] Vaccination in Elite Athletes
    Barbara C. Gärtner
    Tim Meyer
    [J]. Sports Medicine, 2014, 44 : 1361 - 1376
  • [43] Elite athletes and epilepsy
    McGinty, Ronan N.
    Costello, Daniel J.
    [J]. EPILEPSIA, 2016, 57 (06) : 1009 - 1010
  • [44] Vaccination in Elite Athletes
    Gaertner, Barbara C.
    Meyer, Tim
    [J]. SPORTS MEDICINE, 2014, 44 (10) : 1361 - 1376
  • [45] Health of elite athletes
    Le Van, P.
    [J]. BULLETIN DE L ACADEMIE NATIONALE DE MEDECINE, 2019, 203 (05): : 274 - 281
  • [46] Are Elite Athletes Exploited?
    Murphy, Patrick
    Waddington, Ivan
    [J]. SPORT IN SOCIETY, 2007, 10 (02) : 239 - 255
  • [47] The Chronotype of Elite Athletes
    Lastella, Michele
    Roach, Gregory D.
    Halson, Shona L.
    Sargent, Charli
    [J]. JOURNAL OF HUMAN KINETICS, 2016, 54 (01) : 219 - 225
  • [48] Haematocrit in elite athletes
    Vergouwen, PCJ
    Collée, T
    Marx, JJM
    [J]. INTERNATIONAL JOURNAL OF SPORTS MEDICINE, 1999, 20 (08) : 538 - 541
  • [49] Anaesthesia for elite athletes
    Bourgonjon, Bram
    Vermeylen, Kris
    Tytgat, Niek
    Forget, Patrice
    [J]. EUROPEAN JOURNAL OF ANAESTHESIOLOGY, 2022, 39 (10) : 825 - 834
  • [50] Thermoregulation in elite athletes
    Reilly, Thomas
    Drust, Barry
    Gregson, Warren
    [J]. CURRENT OPINION IN CLINICAL NUTRITION AND METABOLIC CARE, 2006, 9 (06): : 666 - 671